Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases.
Front Pharmacol. 2022 Apr 26;13:815646. doi: 10.3389/fphar.2022.815646. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35559231
Free PMC article.